Invesco’s Hemab Therapeutics COAG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$284K Buy
+9,215
New +$404K ﹤0.01% 3472

Other funds holding COAG

Invesco's COAG Position: Q3 2026 in Review

Invesco opened a new position in Hemab Therapeutics (COAG) in Q3 2026: 9,215 shares worth $284K. The stake represents ﹤0.01% of the portfolio and ranks #3472 among its holdings.

89 funds tracked by Wall St. Rank hold COAG as of Q3 2026.

  • Invesco held 9,215 shares of Hemab Therapeutics worth $284K as of Q3 2026.
  • Hemab Therapeutics was a new Invesco position in Q3 2026.
  • Hemab Therapeutics made up ﹤0.01% of Invesco's portfolio in Q3 2026, its #3472 holding.
  • 89 funds tracked by Wall St. Rank held Hemab Therapeutics as of Q3 2026.

Based on Invesco's 13F filing for Q3 2026, filed 12 Nov 2026.